减重手术降低非酒精性脂肪性肝病合并重度肥胖成人的癌症风险
本研究基于MarketScan数据库开展回顾性队列研究,纳入2007至2017年新诊断的非酒精性脂肪性肝病(NAFLD)合并重度肥胖的18至64岁患者共98,090例,其中33,435例(34.1%)接受减重手术。采用Cox比例风险模型及逆概率治疗加权(IPTW)校正混杂后,减重手术与任何癌症风险降低18%(HR 0.82;95%CI 0.76-0.89)及肥胖相关癌症风险降低25%(HR 0.65;95%CI 0.56-0.75)显著相关。
要点
- 减重手术与NAFLD合并重度肥胖患者任何癌症风险降低18%相关。
- 减重手术与肥胖相关癌症风险降低25%相关。
- 结直肠癌、胰腺癌、子宫内膜癌、甲状腺癌、肝细胞癌及多发性骨髓瘤风险显著降低。
核心结论
- 在NAFLD合并重度肥胖成人中,减重手术与任何癌症及肥胖相关癌症风险显著降低相关。
研究设计与样本
- 回顾性队列研究,使用MarketScan数据库,纳入2007至2017年新诊断NAFLD合并重度肥胖的18至64岁患者98,090例,其中33,435例(34.1%)接受减重手术。
- 采用Cox比例风险模型,将减重手术作为时间依存协变量,并使用逆概率治疗加权(IPTW)校正混杂。
主要发现
- 未手术组随访115,890.11人年发生1898例癌症,手术组随访67,389.82人年发生925例癌症(粗率比0.84;95%CI 0.77-0.91)。
- IPTW校正后,减重手术组任何癌症风险降低18%(HR 0.82;95%CI 0.76-0.89),肥胖相关癌症风险降低25%(HR 0.65;95%CI 0.56-0.75)。
- 在癌症特异性模型中,减重手术与结直肠癌、胰腺癌、子宫内膜癌、甲状腺癌、肝细胞癌及多发性骨髓瘤风险显著降低相关。
- 接受手术的肝硬化患者与非肝硬化患者相比,任何癌症及肥胖相关癌症的校正风险均显著更低。
临床怎么用
- 对于NAFLD合并重度肥胖的成人,减重手术可能作为降低癌症风险的策略之一进行个体化评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is associated with obesity and increased risk of cancer. The impacts of bariatric surgery on cancer risk in NAFLD patients are unknown. We investigated the effect of bariatric surgery on cancer risk in patients with NAFLD and severe obesity using the MarketScan database. METHODS: We conducted a retrospective cohort study of 18 to 64 years old newly diagnosed NAFLD patients with severe obesity between 2007 and 2017. We used Cox proportional hazard models to examine the association between bariatric surgery, modeled as a time-varying covariate, and the risks of any cancer and obesity-related cancer, while accounting for confounding using inverse probability of treatment weighting (IPTW). RESULTS: A total of 98,090 patients were included in the study, 33,435 (34.1%) received bariatric surgery. In those without surgery, 1898 incident cases of cancer occurred over 115,890.11 person-years of follow-up, compared with 925 cancer cases over 67,389.82 person-years among surgery patients (crude rate ratio, 0.84; 95% CI, 0.77- 0.91). The IPTW-adjusted risk of any cancer and obesity-related cancer was reduced by 18% (hazard ratio, 0.82; 95% CI, 0.76-0.89) and 25% (hazard ratio, 0.65; 95% CI, 0.56-0.75), respectively, in patients with versus without bariatric surgery. The adjusted risks of any cancer and obesity-related cancer were significantly lower in cirrhotic versus non-cirrhotic patients who underwent surgery. In cancer-specific models, bariatric surgery was associated with significant risk reductions for colorectal, pancreatic, endometrial, thyroid cancers, hepatocellular carcinoma, and multiple myeloma. CONCLUSION: Bariatric surgery was associated with significant reductions in the risks of any cancer and obesity-related cancer in NAFLD patients with severe obesity.
引用
- Rustgi VK, Li Y, Gupta K, et al. Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity. Gastroenterology. 2021. PMID: 33744305. doi:10.1053/j.gastro.2021.03.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。